-
(2R,3R,4S,5R)-2-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
-
ChemBase ID:
6085
-
Molecular Formular:
C12H12Cl2N2O4
-
Molecular Mass:
319.14068
-
Monoisotopic Mass:
318.01741223
-
SMILES and InChIs
SMILES:
c12cc(Cl)c(Cl)cc1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Canonical SMILES:
OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1cc(Cl)c(c2)Cl
InChI:
InChI=1S/C12H12Cl2N2O4/c13-5-1-7-8(2-6(5)14)16(4-15-7)12-11(19)10(18)9(3-17)20-12/h1-2,4,9-12,17-19H,3H2/t9-,10-,11-,12-/m1/s1
InChIKey:
XHSQDZXAVJRBMX-DDHJBXDOSA-N
-
Cite this record
CBID:6085 http://www.chembase.cn/molecule-6085.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2R,3R,4S,5R)-2-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
|
|
|
IUPAC Traditional name
|
(2R,3R,4S,5R)-2-(5,6-dichloro-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
|
|
|
Synonyms
|
5,6-Dichlorobenzimidazole riboside
|
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole
|
5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside
|
5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole
|
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole
|
5,6-DICHLOROBENZIMIDAZOLE RIBOSIDE
|
DRB
|
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole
|
|
|
CAS Number
|
|
MDL Number
|
|
Beilstein Number
|
|
PubChem SID
|
|
PubChem CID
|
|
CHEMBL
|
|
Chemspider ID
|
|
DrugBank ID
|
|
Wikipedia Title
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
ALOGPS 2.1
Acid pKa
|
12.455603
|
H Acceptors
|
5
|
H Donor
|
3
|
LogD (pH = 5.5)
|
0.7447811
|
LogD (pH = 7.4)
|
0.9050076
|
Log P
|
0.9076422
|
Molar Refractivity
|
71.1744 cm3
|
Polarizability
|
29.581772 Å3
|
Polar Surface Area
|
87.74 Å2
|
Rotatable Bonds
|
2
|
Lipinski's Rule of Five
|
true
|
Log P
|
1.01
|
LOG S
|
-2.09
|
Solubility (Water)
|
2.59e+00 g/l
|
DETAILS
DETAILS
MP Biomedicals
DrugBank
Wikipedia
Sigma Aldrich
MP Biomedicals -
02157639
|
Purity: 98% Selectively inhibits casein kinase II. Blocks RNA synthesis by inhibiting RNA polymerase II transcription dependent on CK-II. |
Sigma Aldrich -
D1916
|
Biochem/physiol Actions Inhibitor of RNA synthesis; causes premature termination of transcription. CK2 (casein kinase-2) inhibitor. |
Sigma Aldrich -
35290
|
Biochem/physiol Actions Inhibitor of RNA synthesis; causes premature termination of transcription. CK2 (casein kinase-2) inhibitor. |
PATENTS
PATENTS
PubChem Patent
Google Patent